Project Grant R44OH012425
- The Centers for Disease Control and Prevention awarded Advanced Virology Inc. $279,270 on September 30, 2025, under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283) to develop low-cost and high-efficiency DNA-based reverse genetics platforms for manufacturing RNA virus products. The award funds work through September 29, 2027, at the recipient's Philadelphia, Pennsylvania location. The program supports investigations and technical...
- The Centers for Disease Control and Prevention awarded Esper Biosciences Inc. $614,000 on September 30, 2025, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to develop a rapid point-of-care nucleic acid test for hepatitis C using nanosensors. The award period runs through September 29, 2026, with performance at Esper Biosciences' location in Ithaca, New York. The CDC Investigations and Technical Assistance program supports efforts to control communicable diseases,...
- The Centers for Disease Control and Prevention awarded $907,272 to Hawai'i Innovation Inc. on September 30, 2025, under the CDC Investigations and Technical Assistance program (CFDA 93.283) for METAVEST: Advanced Biomimetic Personal Cooling for Enhancing Heat Safety Among High-Risk Workers. The award is a Project Grant assistance type. Performance and completion are scheduled through September 29, 2026, with work performed in Hawaii. The program funds investigations and technical assistance to...
- The Centers for Disease Control and Prevention awarded a Cooperative Agreement totaling $228,571 to Fund For Public Health In New York, Inc. on September 30, 2026, to prevent foodborne illness in New York City food service settings using informatics tools and advanced data analytics. The award falls under the CDC Investigations and Technical Assistance program (CFDA 93.283), which supports State and local health authorities and other health-related organizations in controlling communicable...
- <p>The Centers for Disease Control and Prevention awarded Anvil Diagnostics Inc. $296,185 on September 30, 2026, under the Protecting and Improving Health Globally program (CFDA 93.318) to develop rapid and highly multiplexed pathogen detection for sepsis patients using compressed sensing and digital PCR.</p> <p>Work is performed in Massachusetts. The period of performance runs from the award date through September 29, 2027. The assistance type is a Project Grant.</p>
- The Centers for Disease Control and Prevention awarded $613,744 to SKM Instruments, Inc. on September 30, 2025, under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084) to develop an ultra-rapid optical platform for antimicrobial susceptibility testing of pulmonary non-tuberculous mycobacterial infections. Performance occurs in Wyoming, with a period of performance extending through May 31, 2026. The project grant supports the development of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded Microsensor Labs, LLC $306,872 on September 1, 2026, to develop a high-throughput automated platform for rapid isolation and testing of Salmonella. The award, made under CFDA 93.318 (Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security), runs through August 31, 2027, with place of performance in Illinois. The project is classified...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded The Trustees of Columbia University in the City of New York $237,764 under the CDC Investigations and Technical Assistance program (CFDA 93.283) on September 1, 2026, to investigate distal airway dysfunction following childhood exposure to the World Trade Center attack and to identify predictors and clinical consequences of that dysfunction. The award funds a two-year project with performance through...
- The Centers for Disease Control and Prevention awarded a $1.992204 million cooperative agreement to the Commonwealth of Virginia State Board of Health, Office of Epidemiology, on September 30, 2025, under the HIV/AIDS Surveillance program (CFDA 93.944) to conduct comprehensive HIV incidence and prevalence monitoring, track risk behaviors, and inform prevention efforts through data collection and targeted testing. The award period runs through September 29, 2030, with place of performance in...
- The Centers for Disease Control and Prevention, operating under the National Institute for Occupational Safety and Health, awarded New York University $243,709 on September 1, 2026, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to support the WTC Survivors: Lifestyle Medicine Study. The project runs through August 31, 2028, with place of performance in New York, New York. The CDC Investigations and Technical Assistance program assists state and local health...
The Centers for Disease Control and Prevention awarded Hava Inc. $455,409 under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283) on September 1, 2026, to develop rapid production methods for metal organic framework fabrics for air filtration. The award supports a project period of performance extending through August 31, 2028, with work performed in Albemarle County, Virginia. The CFDA 93.283 program assists state and local health authorities and other health-related organizations in controlling communicable diseases, chronic diseases and disorders, and other preventable health conditions through investigations and evaluation of control methods. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $455.4k | 8/15/26 |